Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Transferrin-Conjugated Magnetic Dextran-Spermine Nanoparticles for Targeted Drug Transport Across Blood-Brain Barrier Publisher Pubmed



Ghadiri M1 ; Vasheghanifarahani E1 ; Atyabi F2 ; Kobarfard F3 ; Mohamadyartoupkanlou F4 ; Hosseinkhani H5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Biomedical Engineering Division, Faculty of Chemical Engineering, Tarbiat Modares University, PO Box 14115-114, Tehran, Iran
  2. 2. Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 14174, Iran
  3. 3. Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Stem Cell Technology Research Center, Tehran, Iran
  5. 5. Innovation Center for Advanced Technology, Matrix, Inc, New York, 10029, United States

Source: Journal of Biomedical Materials Research - Part A Published:2017


Abstract

Application of many vital hydrophilic medicines have been restricted by blood–brain barrier (BBB) for treatment of brain diseases. In this study, a targeted drug delivery system based on dextran-spermine biopolymer was developed for drug transport across BBB. Drug loaded magnetic dextran-spermine nanoparticles (DS-NPs) were prepared via ionic gelation followed by transferrin (Tf) conjugation as targeting moiety. The characteristics of Tf conjugated nanoparticles (TDS-NPs) were analyzed by different methods and their cytotoxicity effects on U87MG cells were tested. The superparamagnetic characteristic of TDS-NPs was verified by vibration simple magnetometer. Capecitabine loaded TDS-NPs exhibited pH-sensitive release behavior with enhanced cytotoxicity against U87MG cells, compared to DS-NPs and free capecitabine. Prussian-blue staining and TEM-imaging showed the significant cellular uptake of TDS-NPs. Furthermore, a remarkable increase of Fe concentrations in brain was observed following their biodistribution and histological studies in vivo, after 1 and 7 days of post-injection. Enhanced drug transport across BBB and pH-triggered cellular uptake of TDS-NPs indicated that these theranostic nanocarriers are promising candidate for the brain malignance treatment. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 2851–2864, 2017. © 2017 Wiley Periodicals, Inc.